Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ALLERGAN ANNOUNCES U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL OF LATISSE™ -- FIRST AND ONLY TREATMENT APPROVED BY THE FDA FOR HYPOTRICHOSIS OF EYELASHES
ALLERGAN ANNOUNCES U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL OF LATISSE™ -- FIRST AND ONLY TREATMENT APPROVED BY THE FDA FOR HYPOTRICHOSIS OF EYELASHES
ALLERGAN ANNOUNCES U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL OF LATISSE™ -- FIRST AND ONLY TREATMENT APPROVED BY THE FDA FOR HYPOTRICHOSIS OF EYELASHES
Submitted by
admin
on December 27, 2008 - 11:19am
Source:
PR NewsWire
News Tags:
Allergan
Latisse
hypotrichosis
Headline:
ALLERGAN ANNOUNCES U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL OF LATISSE™ -- FIRST AND ONLY TREATMENT APPROVED BY THE FDA FOR HYPOTRICHOSIS OF EYELASHES
Do Not Allow Advertisers to Use My Personal information
